Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122031574 | 12203157 | 4 | F | 20160509 | 20160627 | 20160323 | 20160701 | EXP | PHEH2016US006941 | NOVARTIS | 38.73 | YR | F | Y | 87.80000 | KG | 20160701 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122031574 | 12203157 | 1 | SS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 91.0049973 | MG | N | 0 | .5 | MG | CAPSULE | QD | |||
| 122031574 | 12203157 | 2 | PS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Unknown | N | 10187 | ||||||||||
| 122031574 | 12203157 | 3 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, UNK | 0 | 300 | MG | ||||||||
| 122031574 | 12203157 | 4 | C | ESTROGEN | ESTRONESUS SCROFA OVARY | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122031574 | 12203157 | 1 | Multiple sclerosis |
| 122031574 | 12203157 | 2 | Restless legs syndrome |
| 122031574 | 12203157 | 3 | Product used for unknown indication |
| 122031574 | 12203157 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122031574 | 12203157 | OT |
| 122031574 | 12203157 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122031574 | 12203157 | Abdominal pain upper | |
| 122031574 | 12203157 | Altered visual depth perception | |
| 122031574 | 12203157 | Fatigue | |
| 122031574 | 12203157 | Glare | |
| 122031574 | 12203157 | Hepatic enzyme increased | |
| 122031574 | 12203157 | Multiple sclerosis relapse | |
| 122031574 | 12203157 | Night blindness | |
| 122031574 | 12203157 | Paraesthesia | |
| 122031574 | 12203157 | Restless legs syndrome | |
| 122031574 | 12203157 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122031574 | 12203157 | 1 | 20151109 | 20160511 | 0 | |
| 122031574 | 12203157 | 3 | 2012 | 0 |